GlassScriptPhysician profile
Leigh S Bergmann
NPI 1285759696
$9,709.62
in general payments reported to CMS, 2019-2025
57 companies · $1,949 in 2025
The $1,949 reported for 2025 was more than what 80% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,156 · 2020: $645 · 2021: $862 · 2022: $983 · 2023: $1,434 · 2024: $1,680 · 2025: $1,949.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,979 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,978.84 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,061.20 | 2019-2025 | Erleada |
| Astellas Pharma US INC | $1,011.58 | 2019-2025 | Xtandi, Myrbetriq, Veozah |
| Dendreon Pharmaceuticals LLC | $958.50 | 2019-2025 | Provenge |
| Pfizer INC. | $729.23 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $512.84 | 2019-2025 | |
| Abbvie INC. | $475.52 | 2020-2025 | Botox |
| Tolmar, INC. | $405.90 | 2023-2025 | Jatenzo, Eligard |
| Medtronic, INC. | $399.25 | 2021-2023 | Interstim |
| Sumitomo Pharma America, INC. | $388.96 | 2023-2025 | Gemtesa, Orgovyx |
| Ferring Pharmaceuticals INC. | $387.75 | 2019-2025 | Adstiladrin |
| Karl Storz Endoscopy-America | $345.01 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $275.98 | 2019-2025 | Lynparza |
| Urogen Pharma, INC. | $172.58 | 2021-2025 | |
| Boston Scientific Corporation | $171.38 | 2019-2024 | Lithovue, Spaceoar System, Rezum Generator |
| Amgen INC. | $170.79 | 2019-2021 |
Show all 57 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leigh Bergmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.